Biotech

January 20, 2017

AXIM® Biotech Enters Groundbreaking Clinical Trial Of CBD Gum And IBS

CBD is a nonpsychoactive phytocannabinoid, a unique organic chemical found in the cannabis plant. The natural compound is one of several that…

Read More

January 19, 2017

Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

… from the Medical Ethical Committee (METC) at Wageningen University for the trial using controlled-release hemp oil CBD chewing gum with patients ……

Read More

Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum

19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that ……

Read More

January 10, 2017

Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for …

The single dose study on 10 mg of cannabidiol (CBD) and 30 mg of CBD … Our mission is to be the…

Read More

January 6, 2017

Chewing hemp gum can relieve IBS, says AXIM Biotech

Its products include CanChew, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing ……

Read More

December 29, 2016

AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids …

Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is ……

Read More

December 18, 2016

Axim Biotechnologies Inc (OTCMKTS:AXIM) Cannabinoid Biotech Rising

The move has been driven by the company's advances in chewing gum delivery of THC and CBD for the treatment of pain…

Read More